APO Research
Talk to an analyst

APO RESEARCH · REPORT

Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Industry Growth and Trends Forecast to 2032

22 December 202561 pages

Choose your research edition.

Industry ResearchIdiopathic Thrombocytopenic Purpura (ITP) Therapeutics Industry Research Report 2026100 pages · $2,950 USDIndustry Growth & TrendsGlobal Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Industry Growth and Trends Forecast to 203261 pages · $3,450 USDMarket StructureGlobal Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

According to APO Research, the global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics market include Grifols Biologicals Inc., Amgen Inc, GlaxoSmithKline Plc and Roch, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market by Company

Grifols Biologicals Inc.

Amgen Inc

GlaxoSmithKline Plc

Roch

Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Segment by Type

Thrombopoietin Receptor Agonists (TPO-RA)

Corticosteroids

Anti-D Immunoglobulin

Intravenous Immunoglobulin (IVIG)

Others

Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Segment by Application

Hospitals

Clinics

Others

Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Region (2021-2026) Table 4. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Region (2027-2032) Table 6. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Share by Type (2021-2026) Table 9. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Share Forecasted by Type (2027-2032) Table 11. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Share by Application (2021-2026) Table 24. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Share Forecasted by Application (2027-2032) Table 26. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Industry Trends Table 37. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Industry Drivers Table 38. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Industry Opportunities and Challenges Table 39. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Industry Restraints Table 40. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share by Company (2021-2026) Table 42. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Key Company Headquarters & Area Served Table 44. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Company, Product Type & Application Table 45. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Grifols Biologicals Inc. Company Information Table 49. Grifols Biologicals Inc. Business Overview Table 50. Grifols Biologicals Inc. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Grifols Biologicals Inc. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product Portfolio Table 52. Grifols Biologicals Inc. Recent Development Table 53. Amgen Inc Company Information Table 54. Amgen Inc Business Overview Table 55. Amgen Inc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Amgen Inc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product Portfolio Table 57. Amgen Inc Recent Development Table 58. GlaxoSmithKline Plc Company Information Table 59. GlaxoSmithKline Plc Business Overview Table 60. GlaxoSmithKline Plc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. GlaxoSmithKline Plc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product Portfolio Table 62. GlaxoSmithKline Plc Recent Development Table 63. Roch Company Information Table 64. Roch Business Overview Table 65. Roch Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Roch Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product Portfolio Table 67. Roch Recent Development Table 68. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 69. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 70. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Country (2021-2026) Table 71. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 72. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share Forecast by Country (2027-2032) Table 73. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 74. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 75. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Country (2021-2026) Table 76. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 77. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share Forecast by Country (2027-2032) Table 78. Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 79. Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 80. Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Country (2021-2026) Table 81. Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 82. Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share Forecast by Country (2027-2032) Table 83. Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 84. Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 85. Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Country (2021-2026) Table 86. Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 87. Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share Forecast by Country (2027-2032) Table 88. Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 89. Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 90. Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Country (2021-2026) Table 91. Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 92. Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share Forecast by Country (2027-2032) Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product Image Figure 3. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size (2021-2032) & (US$ Million) Figure 5. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Region: 2025 VS 2032 Figure 6. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Region (2021-2032) Figure 7. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Thrombopoietin Receptor Agonists (TPO-RA) Image Figure 13. Global Thrombopoietin Receptor Agonists (TPO-RA) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Corticosteroids Image Figure 15. Global Corticosteroids Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Anti-D Immunoglobulin Image Figure 17. Global Anti-D Immunoglobulin Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Intravenous Immunoglobulin (IVIG) Image Figure 19. Global Intravenous Immunoglobulin (IVIG) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Others Image Figure 21. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Type 2025 VS 2032 Figure 24. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Share by Type (2021-2032) Figure 25. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Share by Type (2021-2032) Figure 27. Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Share by Type (2021-2032) Figure 29. Hospitals Image Figure 30. Global Hospitals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Clinics Image Figure 32. Global Clinics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Others Image Figure 34. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Application 2025 VS 2032 Figure 37. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Share by Application (2021-2032) Figure 38. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Share by Application (2021-2032) Figure 40. Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Country (2021-2032) Figure 47. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Country (2021-2032) Figure 50. Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Country (2021-2032) Figure 53. Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Country (2021-2032) Figure 56. Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Thrombopoietin Receptor Agonists (TPO-RA)
  • Corticosteroids
  • Anti-D Immunoglobulin
  • Intravenous Immunoglobulin (IVIG)
  • Others
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Grifols Biologicals Inc.
  • Amgen Inc
  • GlaxoSmithKline Plc
  • Roch

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Region (2021-2032)
  5. 1.4.1 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Region (2021-2026)
  6. 1.4.2 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Region (2027-2032)
  7. 1.5 Key Regions Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size (2021-2032)
  8. 1.5.1 North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate (2021-2032)
2 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Thrombopoietin Receptor Agonists (TPO-RA)
  3. 2.1.2 Corticosteroids
  4. 2.1.3 Anti-D Immunoglobulin
  5. 2.1.4 Intravenous Immunoglobulin (IVIG)
  6. 2.1.5 Others
  7. 2.2 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Type
  8. 2.2.1 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Regions
  12. 2.3.1 North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Breakdown by Type (2021-2026)
3 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospitals
  3. 3.1.2 Clinics
  4. 3.1.3 Others
  5. 3.2 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Application
  6. 3.2.1 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Regions
  10. 3.3.1 North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Industry Trends
  2. 4.2 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Industry Drivers
  3. 4.3 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Industry Opportunities and Challenges
  4. 4.4 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue (2021-2026)
  2. 5.2 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Key Company Headquarters & Area Served
  4. 5.4 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Company, Product Type & Application
  5. 5.5 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Grifols Biologicals Inc.
  2. 6.1.1 Grifols Biologicals Inc. Company Information
  3. 6.1.2 Grifols Biologicals Inc. Business Overview
  4. 6.1.3 Grifols Biologicals Inc. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Grifols Biologicals Inc. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product Portfolio
  6. 6.1.5 Grifols Biologicals Inc. Recent Developments
  7. 6.2 Amgen Inc
  8. 6.2.1 Amgen Inc Company Information
  9. 6.2.2 Amgen Inc Business Overview
  10. 6.2.3 Amgen Inc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Amgen Inc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product Portfolio
  12. 6.2.5 Amgen Inc Recent Developments
  13. 6.3 GlaxoSmithKline Plc
  14. 6.3.1 GlaxoSmithKline Plc Company Information
  15. 6.3.2 GlaxoSmithKline Plc Business Overview
  16. 6.3.3 GlaxoSmithKline Plc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 GlaxoSmithKline Plc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product Portfolio
  18. 6.3.5 GlaxoSmithKline Plc Recent Developments
  19. 6.4 Roch
  20. 6.4.1 Roch Company Information
  21. 6.4.2 Roch Business Overview
  22. 6.4.3 Roch Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Roch Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product Portfolio
  24. 6.4.5 Roch Recent Developments
7 North America
  1. 7.1 North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2021-2026)
  3. 7.3 North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2021-2026)
  3. 8.3 Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2021-2026)
  3. 10.3 South America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst